Thermo Fisher Scientific (TMO) : Aureus Asset Management scooped up 2,380 additional shares in Thermo Fisher Scientific during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 100,019 shares of Thermo Fisher Scientific which is valued at $14.8 Million.Thermo Fisher Scientific makes up approximately 3.32% of Aureus Asset Management’s portfolio.
Other Hedge Funds, Including , Public Sector Pension Investment Board reduced its stake in TMO by selling 37,600 shares or 36.9% in the most recent quarter. The Hedge Fund company now holds 64,301 shares of TMO which is valued at $9.5 Million. Thermo Fisher Scientific makes up approx 0.11% of Public Sector Pension Investment Board’s portfolio.Girard Partners Ltd. boosted its stake in TMO in the latest quarter, The investment management firm added 786 additional shares and now holds a total of 16,186 shares of Thermo Fisher Scientific which is valued at $2.4 Million. Thermo Fisher Scientific makes up approx 1.06% of Girard Partners Ltd.’s portfolio.State Treasurer State Of Michigan boosted its stake in TMO in the latest quarter, The investment management firm added 10,900 additional shares and now holds a total of 950,403 shares of Thermo Fisher Scientific which is valued at $139.7 Million. Thermo Fisher Scientific makes up approx 1.11% of State Treasurer State Of Michigan’s portfolio.Geneva Advisors reduced its stake in TMO by selling 20 shares or 0.18% in the most recent quarter. The Hedge Fund company now holds 10,913 shares of TMO which is valued at $1.6 Million. Thermo Fisher Scientific makes up approx 0.03% of Geneva Advisors’s portfolio.
Thermo Fisher Scientific opened for trading at $150.84 and hit $151.68 on the upside on Wednesday, eventually ending the session at $151.16, with a gain of 0.32% or 0.48 points. The heightened volatility saw the trading volume jump to 13,11,933 shares. Company has a market cap of $59,483 M.
On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.
Investors should note that on May 18, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Jun 13, 2016 as the ex-dividend date and fixed the record date on Jun 15, 2016. The payable date has been fixed on Jul 15, 2016.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.